Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : ciclosporine
  • Topics : Kidney diseases
  • Producer : industriels
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Urologic diseases (1)
    • Plus ...
      • Kidney diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Manufacturer
  • industriels (1)
Language
  • Français (1)
Active substance
  • acide ascorbique (1)
  • ciclosporine (1)
  • cisplatine (1)
  • iohexol (1)
  • lithium (1)
  • phosphate (1)
  • tacrolimus (1)

Drugs, devices and medical acts - 1 result

  • Assessment of albumin/creatinine ratio in the diagnosis of chronic kidney disease in adults

    Health technology assessment - Posted on 28/12/2011
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
7P7aErbuv1Z5AYRF